KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001827505-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | May 26, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
14,361
Total Value
$49,845.77
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 6,250 | โ | โ | 57,641 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | May 22, 2026 | Sale | 1,861 | $26.78 | $49,845.77 | 55,780 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Unit | Derivative | May 21, 2026 | Exercise/Conversion | 6,250 | $0.00 | $0.00 | 68,750 | Direct | โ | View Details |